cytarabine has been researched along with Maxillary Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ayémou, R; Koffi, GK; Kouakou, B; Nanho, CD; Sanogo, I; Sawadogo, D; Siransi-Bogui, L; Tolo-Diebkilé, A | 1 |
Gutjahr, P; Jung, H | 1 |
2 other study(ies) available for cytarabine and Maxillary Neoplasms
Article | Year |
---|---|
[Evaluation of the protocol CMA reinforced in the treatment of endemic Burkitt lymphoma at CHU of Yopougon in Abidjan].
Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cote d'Ivoire; Cyclophosphamide; Cytarabine; Facial Neoplasms; Female; Humans; Infant; Infant, Newborn; Male; Maxillary Neoplasms; Methotrexate; Remission Induction | 2010 |
[Burkitt's tumor: etiology, clinic and therapy (author's transl)].
Topics: Adolescent; Adult; Africa, Central; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Female; Herpesvirus 4, Human; Humans; Male; Mandibular Neoplasms; Maxillary Neoplasms; Methotrexate; Prognosis; Vincristine | 1974 |